1. Arnett CD, Fowler J, Wolf AP, Logan J, MacGregor R (1984) Mapping brain neuroleptic receptors in the live baboon. Biol Psychiatry 19: 1365–1375
2. Arnett CD, Wolf AP, Shiue CY, Fowler JS, MacGregor RR, Christman DR, Smith MR (1986) Improve delineation of human dopamine receptors using (18F)-N- methylspiroperidol and PET. J Nucl Med 27: 1878–1882
3. Barrio JR, Satyamurthy N, Hoffman JM, Huang SC, Mazziotta JC, Bida GT, Keen RE, Hawkins RA, Ninnenson CH, Phelps ME (1987) In vivo binding of 3-(2′(18F)fluoroethyl)spiperone (FESP) to dopamine D2 receptors: from rodents to humans. J Cereb Blood Flow Metab 7: S357
4. Baron JC, Mazière B, Loc’h C, Cambon H, Sgouropoulos P, Bonnet AM, Agid Y (1986) Loss of striatal (76 Br)bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab 6: 131–136
5. Clémens JA, Smalstig EB, Schaar CJ (1975) Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action. Acta Endocrinol (Copenh) 79: 230–237